Scientists test new kidney Drug's safety with common heart and gout medications
NCT ID NCT07181265
Summary
This early-stage study aims to understand how a new experimental drug for inherited kidney disease interacts with two existing medications (amiodarone for heart rhythm and febuxostat for gout). Researchers will give all three drugs to 48 healthy Chinese volunteers to measure how the body processes them together. The goal is to gather safety data before testing the new drug in actual patients with polycystic kidney disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.